SCHEMBL3022734

SCHEMBL3022734

CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)OC(=O)[C@H](CCC(=O)O)NC(=O)CCCCCCCCCCCCCCCCC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOD1 Q9Y239 7/20 0.61
PLA2G2C Q5R387 1/20 0.61
PLA2G10 O15496 2/20 0.57
KMT2A Q03164 3/20 0.56
FAAH O00519 2/20 0.51
MEN1 O00255 1/20 0.51
MAPK1 P28482 1/20 0.51
POLB P06746 1/20 0.50
HSP90AA1 P07900 1/20 0.47
GPR84 Q9NQS5 2/20 0.47
PPARG P37231 2/20 0.47
PPARD Q03181 2/20 0.47
PPARA Q07869 2/20 0.47
ALDH1A1 P00352 1/20 0.47
TSHR P16473 1/20 0.47
SLC22A6 Q4U2R8 1/20 0.47
SLC22A8 Q8TCC7 1/20 0.47
TLR2 O60603 1/20 0.47
HDAC11 Q96DB2 1/20 0.47
TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3026897 1.00 NOD1 (0.61) NOD1PLA2G2CPLA2G10KMT2AFAAH
SCHEMBL30315957 0.93 NOD1 (0.57) NOD1PLA2G2CPLA2G10KMT2AFAAH
SCHEMBL18796603 0.91 NOD1 (0.61) NOD1PLA2G2CPLA2G10KMT2AFAAH
SCHEMBL9743924 0.91 NOD1 (0.61) NOD1PLA2G2CPLA2G10KMT2AFAAH
SCHEMBL8620768 0.91 NOD1 (0.61) NOD1PLA2G2CPLA2G10KMT2AFAAH
SCHEMBL8620766 0.91 NOD1 (0.61) NOD1PLA2G2CPLA2G10KMT2AFAAH
SCHEMBL17446733 0.91 NOD1 (0.61) NOD1PLA2G2CPLA2G10KMT2AFAAH
SCHEMBL17446821 0.91 NOD1 (0.61) NOD1PLA2G2CPLA2G10KMT2AFAAH
SCHEMBL5025135 0.91 NOD1 (0.61) NOD1PLA2G2CPLA2G10KMT2AFAAH
SCHEMBL8015621 0.91 NOD1 (0.61) NOD1PLA2G2CPLA2G10KMT2AFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1891924-B1 COMPOSITION FOR PROTECTION OF BODY SURFACE ASAHI CHEMICAL IND (JP) 2016-11-16 EP disclosed
US-20100215603-A1 Body Surface Protecting Composition ASAHI KASEI CHEMICALS CORPORATION (JP) 2010-08-26 US disclosed
EP-1891924-A1 COMPOSITION FOR PROTECTION OF BODY SURFACE Asahi Kasei Chemicals Corporation (JP) 2008-02-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100215603-A1 Body Surface Protecting Composition FABP2, CUTA, FABP1 NOD1 1920/4885PLA2G2C 1221/4885PLA2G10 1165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.